ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1930

Patients’ Response To a Sleep Question and Disease Activity In Multiple Rheumatic Conditions

Sapna Sangani1 and Martin J. Bergman2, 1Medicine, Mercy Catholic Medical Center, Lansdowne, PA, 2Medicine, Drexel University College of Medicine, Philadelphia, PA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Disease Activity, rheumatic disease and sleep apnea

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Health Services Research, Quality Measures and Quality of Care - Innovations in Health Care Delivery

Session Type: Abstract Submissions (ACR)

Patient’s Response To A Sleep Question And Disease Activity Levels In Multiple Rheumatic Conditions

Background/Purpose:

Sleep disturbances can have an impact on the quality of life of any individual. Research studies have shown a significant association between sleep disturbances and a number of chronic inflammatory conditions, including Asthma and Crohn’s disease. This study aims to determine the significance of sleep disturbances in patients diagnosed with various rheumatic conditions, and its association with disease activity levels.  

Methods:

All patients with any rheumatologic diagnosis attending a single rheumatology practice were asked to complete a MDHAQ. The MDHAQ includes sections regarding function, pain, patient global estimate, a patient self-reported joint count, fatigue, exercise, AM stiffness and a brief psychological profile. The MDHAQ includes 3 psychological profile queries, including “Over the past week, were you able to get a good night’s sleep?” The responses are 0-3 which stand for, 0=without difficulty, 1= with some difficulty, 2= with much difficulty, 3=unable to do. RAPID3 is an index of the 3 patient-reported outcome measures: physical function, pain and patient global estimate. RAPID3 can be calculated from a MDHAQ in less than 10 seconds. Patients are then characterized into disease activity categories (“remission”, “low disease activity”, “moderate disease activity”, “high disease activity”), according to established criteria. Using a random visit for each patient, linear regression models were determined using the composite score value as the dependent variable, and “sleep” as the independent variable, to determine possible interactions between “sleep”score and  disease activity scores.  All statistical analyses were performed using Stata v12.

Results:

We analyzed data on total of 786 patients diagnosed with a non-overlapping rheumatic disease and who had completed the MDHAQ survey. The number of patients diagnosed with a particular rheumatic disease is shown in the table below. The rheumatic conditions studied are Rheumatoid Arthritis (RA), Osteoarthritis (OA), Fibromyalgia, SLE, Psoriatic Arthritis (PsA), Spondyloarthropathies, and Gout. A “linear” worsening of RAPID3 was seen with each increment of sleep variable.

(Table)

Conclusion:

Interestingly, patients affected by a myriad of chronic inflammatory rheumatic diseases perceive significant sleep disturbances, at any given point of time during the course of their disease process. Patients with worse sleep scores are  less likely to be in low disease activity as measured  by RAPID3. Interventions in chronic rheumatic diseases are often targeted to impact symptoms of joint pain / function. Further interventions may be needed to improve strategies designed for the improvement of psychological profile, especially sleep disorders.

Rheumatic conditions

Observation

Sleepinc=0 (p-value)

Sleepinc=1 (p-value)

Sleepinc=2 (p-value)

Sleepinc=3 (p-value)

R-squared

Rheumatoid Arthritis (RA)

195

5.38 (<0.01)

10.69 (<0.01)

15.45 (<0.01)

17.40 (<0.01)

0.33

Osteoarthritis (OA)

232

9.31 (<0.01)

11.38 (<0.01)

15.73 (<0.01)

17.98 (<0.01)

0.17

Fibromyalgia

52

9.96 (<0.01)

13.51 (<0.01)

18.39 (<0.01)

19.79 (<0.01)

0.25

SLE

53

4.54 (0.003)

8.4 (<0.01)

13.91 (<0.01)

12.16 (0.008)

0.23

Psoriatic Arthritis (PsA)

60

5.34 (<0.01)

10.35 (<0.01)

16.24 (<0.01)

19.77 (<0.01)

0.42

Spondyloarthropathies

113

4.82 (<0.01)

10.04 (<0.01)

16.96 (<0.01)

20.16 (<0.01)

0.52

Gout

81

5.20 (<0.01)

9.82 (<0.01)

17.10 (<0.01)

21.05 (<0.01)

0.37


Disclosure:

S. Sangani,
None;

M. J. Bergman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-response-to-a-sleep-question-and-disease-activity-in-multiple-rheumatic-conditions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology